News & Events
Announcing New Partnership with Delve Health
August 6, 2024 — Minneapolis, MN — Delve Health, a leader in decentralized clinical trial solutions, is excited to announce a strategic partnership with Strados Labs, an innovator in respiratory health technology. This collaboration aims to enhance remote patient...
Strados Labs announces successful completion of pediatric asthma study
Strados Labs, a digital health company focused on improving the lives of patients with respiratory diseases, announced today the successful completion of a recent study of its technology in pediatric asthma, which took place at Ann & Robert H. Lurie Children’s...
Strados to Participate in DiMe Project: Building the Business Case for Digital Endpoints
Strados Labs is excited to announce its participation in a groundbreaking project led by the Digital Medicine Society (DiMe), a global non-profit dedicated to driving scientific progress and broad acceptance in digital medicine. The project, Building the Business Case...
Strados Labs featured at the Respiratory Innovation Summit at ATS 2024
Strados Labs returned to the Respiratory Innovation Summit (RIS), taking place at ATS 2024 in San Diego, CA where Strados was also an exhibitor (Booth 1131). RIS took place from May 17-18. Hosted by the American Thoracic Society, the Respiratory Innovation Summit...
Strados Labs Hits 10 Million Breaths!
This milestone marks a significant step towards advancing respiratory care by harnessing the power of data and innovation. Here’s to countless more breaths captured and making every breath count!
Strados Labs Announces Pediatric Asthma Study to Validate its Wearable Device in Children with Wheeze
PHILADELPHIA, PA - September 26th, 2023 – Strados Labs has partnered with Ann & Robert H. Lurie Children’s Hospital of Chicago for a clinical trial to evaluate the effectiveness of its RESP™ Biosensor in children presenting with wheeze. The RESP™ Biosensor – a...
Upcoming Events
Stay up to date!
Subscribe for updates on news and where we’re headed next.